Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MTNB

Matinas Biopharma Holdings Inc

May 29 • 04:00PM ET

0.8100

+0.0155 1.95 %

Healthcare • Biotechnology • USA • Nano • AMEX

Peers: APRE BCDA BIVI CALC CVM GOVX KAPA KPRX LNAI NEUP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.02	Insider Own	18.82%	Shs Outstand	6.41M	Perf Week	20.91%
Market Cap	5.19M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	5.20M	Perf Month	32.14%
Enterprise Value	3.93M	PEG	-	EPS next Q	-	Inst Own	5.68%	Short Float	0.01%	Perf Quarter	33.22%
Income	-11.23M	P/S	-	EPS this Y	-	Inst Trans	-4.50%	Short Ratio	0.00	Perf Half Y	11.79%
Sales	0.00M	P/B	1.72	EPS next Y	-	ROA	-125.39%	Short Interest	0.00M	Perf YTD	38.23%
Book/sh	0.47	P/C	2.12	EPS next 5Y	-	ROE	-241.67%	52W High	3.09 -73.79%	Perf Year	-6.21%
Cash/sh	0.38	P/FCF	-	EPS past 3/5Y	25.49% 19.44%	ROIC	-321.63%	52W Low	0.48 68.75%	Perf 3Y	-96.14%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	16.28% 14.16%	Perf 5Y	-97.90%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	49.11%	Oper. Margin	-	ATR (14)	0.08	Perf 10Y	-96.82%
Dividend Ex-Date	-	Quick Ratio	1.32	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	73.29	Recom	2.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.32	EPS Q/Q	7.86%	SMA20	23.83%	Beta	1.67	Target Price	30.00
Payout	-	Debt/Eq	0.39	Sales Q/Q	-	SMA50	35.28%	Rel Volume	0.30	Prev Close	0.79
Employees	4	LT Debt/Eq	0.16	Earnings	-	SMA200	-19.26%	Avg Volume	136.60K	Price	0.81
IPO	Jul 21, 2014	Option/Short	No / Yes	EPS/Sales Surpr.	19.43% -	Trades		Volume	40,357	Change	1.95%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)